Immediate Impact
1 from Science/Nature 69 standout
Citing Papers
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
2025 Standout
Works of Sam Hyun Kwon being referenced
The persistence of fatty liver has a differential impact on the development of diabetes: The Kangbuk Samsung Health Study
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Sam Hyun Kwon | 235 | 132 | 84 | 103 | 44 | 517 | |
| Ignacio Javier Fernandez | 290 | 226 | 62 | 85 | 56 | 474 | |
| Ahmet Kutluhan | 272 | 217 | 31 | 64 | 79 | 645 | |
| Zehra Hilal Adıbelli | 231 | 82 | 43 | 45 | 59 | 573 | |
| Jin‐Young Min | 218 | 204 | 23 | 122 | 35 | 478 | |
| Benjamin B. Cable | 259 | 160 | 28 | 140 | 41 | 631 | |
| Shirish Degwekar | 113 | 62 | 28 | 125 | 32 | 580 | |
| Hakan Çankaya | 165 | 124 | 15 | 72 | 53 | 533 | |
| Nilda Süslü | 182 | 189 | 24 | 92 | 45 | 534 | |
| İsrafil Orhan | 209 | 128 | 14 | 82 | 50 | 502 | |
| Jerome C. Goldstein | 223 | 151 | 29 | 34 | 32 | 466 |
All Works
Login with ORCID to disown or claim papers
Loading papers...